Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/2022 → 30/09/2026 |
Funding
- Helperby Therapeutics Group Limited: £65,443.00
Investigating the in vitro and in vivo efficacy of combination therapies with the small-quinolone like compound HT61 against pulmonary infections with the MDR gram-negative ESKAPE pathogens P. aeruginosa, K. pneumoniae and A. baumannii
- Amison, Richard (Primary Investigator)
- Page, Clive (Co-Investigator)
Project: Research